Celestica (CLS) PT Raised at RBC Capital After 'Another Strong Quarterly Beat & Raise'

RBC Capital analyst Paul Treiber raised the price target on Celestica (NYSE: CLS) to $400.00 (from $315.00) while maintaining a Outperform rating.

The analyst commented: "Celestica reported another strong quarterly beat and raise. Celestica's momentum with hyperscalers continues to surprise to the upside, as shown by initial FY26 guidance well above expectations. With high visibility to sustained >25% growth, further margin expansion and Celestica's shift to higher quality business segments, we see Celestica's valuation premium being sustained. Maintain Outperform, price target moves from $315.00 to $400.00."

You May Also Be Interested In

• Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
• Wolverine World Wide (WWW) PT Raised to $20 at Williams Trading
• Moderna (MRNA) PT Raised to $89 at Morgan Stanley